Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> New Initiative to Tackle Alcohol Harms Will Focus on Taxation 01/11/2022 Kerry Cullinan A $15 million initiative to address the harms of alcohol consumption through policy change was launched Tuesday, roughly doubling the total global spending on mitigating the effects of alcohol. Alcohol is one of the top-ten drivers of death, illness and injury, with wide-ranging social and economic harms, many disproportionately affecting young adults, according to Vital […] Continue reading -> TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shorter Treatment Regimen for Drug-Resistant TB is More Effective 08/11/2022 Kerry Cullinan Two shorter treatment regimens for multi-drug resistant (MDR) tuberculosis have proven to be safe and more effective than the current treatment, the Union World Conference on Lung Health heard on Tuesday. Results from Stage 2 of the STREAM clinical trial, published in The Lancet on the same day, show that a fully-oral nine-month bedaquiline-based regimen […] Continue reading -> New Initiative to Tackle Alcohol Harms Will Focus on Taxation 01/11/2022 Kerry Cullinan A $15 million initiative to address the harms of alcohol consumption through policy change was launched Tuesday, roughly doubling the total global spending on mitigating the effects of alcohol. Alcohol is one of the top-ten drivers of death, illness and injury, with wide-ranging social and economic harms, many disproportionately affecting young adults, according to Vital […] Continue reading -> TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Initiative to Tackle Alcohol Harms Will Focus on Taxation 01/11/2022 Kerry Cullinan A $15 million initiative to address the harms of alcohol consumption through policy change was launched Tuesday, roughly doubling the total global spending on mitigating the effects of alcohol. Alcohol is one of the top-ten drivers of death, illness and injury, with wide-ranging social and economic harms, many disproportionately affecting young adults, according to Vital […] Continue reading -> TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy